Skip to main content
Clinical Trials/NCT02423551
NCT02423551CompletedNot Applicable

Effects of Meal, Ready-to-Eat (MRE) Consumption on Gut Health

United States Army Research Institute of Environmental Medicine1 site in 1 country71 target enrollmentStarted: April 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
71
Locations
1
Primary Endpoint
Change in gut barrier integrity

Study Overview

Brief Summary

The objective of this study is to determine the impact of consuming MREs as the sole source of subsistence for 21 days on gut bacteria community composition and gut health. Up to 80 free-living adults will be randomized to consume their usual diet or only MREs for 21 consecutive days. MREs will be provided by the Military Nutrition Division, US Army Research Institute of Environmental Medicine (USARIEM). Fecal, urine and blood samples will be collected periodically before, during and after the intervention to measure gut barrier integrity, gut bacteria community composition, and markers of gut health, inflammation, and nutritional status.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 62 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •BMI </= 30

Exclusion Criteria

  • •Use of antiobiotcs within 3 months of study participation
  • •Use of pro- or prebiotic supplements within 2 weeks of study participation
  • •Vegetarian diets
  • •Use of laxatives, stool softeners, or anti-diarrheal medications at least once a week.
  • •Fewer than 4 bowel movements, on average, per week
  • •History of gastrointestinal disease
  • •Colonoscopy within 3 months of study participation
  • •Food allergies or aversions or other issues with foods that would preclude MRE consumption, including gluten, milk, nuts, or eggs.
  • •Use non-steroidal anti-inflammatory medications (NSAIDs) or antihistamine prescribed by a physician or clinician, or unwillingness to discontinue the use of these substances during the study.
  • •Actively trying to lose weight
  • •Pregnant or lactating
  • •Recent blood donation

Arms & Interventions

MRE

Experimental

MRE consumption

Intervention: MRE (Other)

Control

No Intervention

Usual diet

Outcomes

Primary Outcomes

Change in gut barrier integrity

Time Frame: Baseline to 10 days, 21 days and 31 days

Urine excretion of saccharide probes; circulating zonulin, intestinal fatty acid binding protein, claudin-3, lipopolysaccharide and GLP2 concentrations

Secondary Outcomes

  • Change in vitamin D status(Baseline to 10 days, 21 days and 31 days)
  • Change in nutritional status(Baseline to 10 days, 21 days and 31 days)
  • Change in interleukin-6 concentrations(Baseline to 10 days, 21 days and 31 days)
  • Change in lipopolysaccharide concentrations(Baseline to 10 days, 21 days and 31 days)
  • Change in iron status(Baseline to 10 days, 21 days and 31 days)
  • Change in B-vitamin status(Baseline to 10 days, 21 days and 31 days)
  • Change in zinc status(Baseline to 10 days, 21 days and 31 days)
  • Change in gut microbiota composition(Baseline to 10 days, 21 days and 31 days)
  • Change in TNF-alpha concentrations(Baseline to 10 days, 21 days and 31 days)
  • Change in calcium absorption(Baseline to 10 days, 21 days and 31 days)
  • Change in C-reactive protein concentrations(Baseline to 10 days, 21 days and 31 days)

Investigators

Sponsor
United States Army Research Institute of Environmental Medicine
Sponsor Class
Fed
Responsible Party
Principal Investigator
Principal Investigator

James Philip Karl

Research Dietitian

United States Army Research Institute of Environmental Medicine

Study Sites (1)

Loading locations...

Similar Trials